Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spapen, H.
Right arrow Articles by Huyghens, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spapen, H.
Right arrow Articles by Huyghens, L.
(Chest. 1998;113:1616-1624.)
© 1998 American College of Chest Physicians

Does N-Acetyl-L-Cysteine Influence Cytokine Response During Early Human Septic Shock?

Herbert Spapen MD1; Haibo Zhang MD, PhD2; Christian Demanet MD3; Wim Vleminckx MD1; Jean-Louis Vincent MD, PhD, FCCP2; and Luc Huyghens MD, PhD, FCCP1

1 From the Department of Intensive Care, Erasme University Hospital, Université Libre de Rruxelles, Brussels, Belgium
2 From the Academic Hospital, Vrije Universiteit, and the Department of Intensive Care, Erasme University Hospital, Université Libre de Rruxelles, Brussels, Belgium
3 From the Department of Hematology and Immunology, Erasme University Hospital, Université Libre de Rruxelles, Brussels, Belgium

Study objective: To assess the effects of adjunctive treatment with N-acetyl-L-cysteine (NAC) on hemodynamics, oxygen transport variables, and plasma levels of cytokines in patients with septic shock.

Design: Prospective, randomized, double-blind, placebo-controlled study.

Setting: A 24-bed medicosurgical ICU in a university hospital.

Patients: Twenty-two patients included within 4 h of diagnosis of septic shock.

Interventions: Patients were randomly allocated to receive either NAC (150 mg/kg bolus, followed by a continuous infusion of 50 mg/kg over 4 h; n=12) or placebo (n=10) in addition to standard therapy.

Measurements: Plasma concentrations of tumor necrosis factor-agr (TNF), interleukin (IL)-6, IL-8, IL-10, and soluble tumor necrosis factor-agr receptor-p55 (sTNFR-p55) were measured by sensitive immunoassays at 0, 2, 4, 6 and 24 h. Pulmonary artery catheter-derived hemodynamics, blood gases, hemoglobin, and arterial lactate were measured at baseline, after infusion (4 h), and at 24 h.

Results: NAC improved oxygenation (PaO2/FIO2 ratio, 214±97 vs 123±86; p<0.05) and static lung compliance (44±11 vs 31±6 L/cm H2O; p<0.05) at 24 h. NAC had no significant effects on plasma TNF, IL-6, or IL-10 levels, but acutely decreased IL-8 and sTNFR-p55 levels. The administration of NAC had no significant effect on systemic and pulmonary hemodynamics, oxygen delivery, and oxygen consumption. Mortality was similar in both groups (control, 40%; NAC, 42%) but survivors who received NAC had shorter ventilator requirement (7±2 days vs 20±7 days; p<0.05) and were discharged earlier from the ICU (13±2 days vs 32±9 days; p<0.05).

Conclusion: In this small cohort of patients with early septic shock, short-term IV infusion of NAC was well-tolerated, improved respiratory function, and shortened ICU stay in survivors. The attenuated production of IL-8, a potential mediator of septic lung injury, may have contributed to the lung-protective effects of NAC.

Key Words: antioxidants • ARDS • cytokines • glutathione • hemodynamics • lung compliance • N-acetyl-L-cysteine • oxygenation • septic shock

Submitted on May 21, 1997
Accepted on November 7, 1997




This article has been cited by other articles:


Home page
BloodHome page
S. Vlahopoulos, I. Boldogh, A. Casola, and A. R. Brasier
Nuclear Factor-kappa B-Dependent Induction of Interleukin-8 Gene Expression by Tumor Necrosis Factor alpha : Evidence for an Antioxidant Sensitive Activating Pathway Distinct From Nuclear Translocation
Blood, September 15, 1999; 94(6): 1878 - 1889.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American College of Chest Physicians.